Verisante Aura is an innovative non-invasive Raman spectroscopy system designed to help medical professionals in the detection of skin cancer. The system is capable of identifying spectral changes associated with the biochemistry of skin cancer cells in less than a second, providing immediate results and valuable information. Developed by the BC Cancer Agency and the University of British Columbia Faculty of Medicine, this patented technology has already been used in a human clinical study spanning six years on approximately 1,000 lesions. Clinical results published in 2012 showed the technology provided a statistically significant improvement in the detection of skin cancer. This diagnostic tool will greatly aid healthcare professionals, lowering healthcare costs through reduced wait times and helping to facilitate early detection. Verisante Aura will help to automate the current process of diagnosis, allowing rapid scanning of the 20-40 skin lesions on at-risk individuals.